What is "ucb"

UCB (Union chimique belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenues of €3.3 billion that focuses primarily on R&D, specifically involving medications centered on Epilepsy, Parkinson's, & Crohn's diseases. The Company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders (including epilepsy), inflammatory disorders (including allergy), and oncology.

Every 3 years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee.